7th AML Academy and SAL autumn meeting 2024
Study Alliance Leukemia – AML Cooperative Group – CELL

Scandic Hotel Frankfurt/Main or online via Zoom
14th/15th November 2024

Dear members of the SAL and AMLCG study groups,
Dear members of CELL,

we are pleased to invite you to the 6th AML Academy and Fall Meeting of the SAL and AMLCG Study Groups on November 16–17, 2023.

The event will be hybrid at the Scandic Hotel in Frankfurt/Main and online via Zoom. More information will follow, but please keep the date free in your calendar.

We are already looking forward to our meeting.

Kind regards,

Prof. Dr. med. Martin Bornhäuser
Medical Clinic and Polyclinic 1, University Hospital Dresden

Prof. Dr. med. Christoph Röllig
Medical Clinic and Polyclinic 1, University Hospital Dresden
SAL Study Center

Thursday, 16th November 2023

13:00 – 13:10

AML Academy I

News from IDH mutations in AML

13:35 – 14:00
Risk stratification in RUNX1 mutated disease


14:30 – 14:55
Update on CAR-T cell options in AML

14:55 – 15:20
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis

15:20– 15:45
CDK7/12/13 inhibition and venetoclax in acute myeloid leukemia


16:15 – 16:40
Prognostic impact of Secondary Type Mutations in AML

16:40 – 17:05
Real-world data on Gemtuzumab Ozogamicin

AML Academy II

17:30 – 18:00
Targeted treatment in AML: My standards and my future bets
Wolach (BeiGene)

18:00 – 18:30
Allo HCT: About the optimal timing and best maintenance
Craddock (Abbvie)

18:30 – 19:15
How I treat newly diagnosed AML
Pratz (Jazz)

19:15 – 19:30
Closing remarks

From 20:00
Networking dinner

Friday, 17th November 2023

SAL-AMLCG Steering Committee Meeting

08:00 – 10:00

Joint Study Group Meeting of SAL, AMLCG

10:30 – 13:00
Updates on current, past and future projects and trials


Joint Study Group Meeting of SAL, AMLCG

14:00 – 16:00
Updates on current, past and future projects and trials


Sophie Steinhäuser, Kiel

Tobias Herold, München

Tim Sauer, Heidelberg

Karsten Spiekermann, München

Caroline Pabst, Heidenberg

Marius Bill, Dresden

Philippe Muller, Essen

Ofir Wolach, Tel Aviv

Charles Craddock, Birmingham

Keith Pratz, Philadelphia

Main sponsor Jazz Pharmaceuticals Germany GmbH presents:

Pfizer presents:

AbbVie Deutschland GmbH & Co. KG presents:

Otsuka Pharma GmbH presents:

Astellas Pharma GmbH presents:

BeiGene presents:


Prof. Dr. med. Christoph Röllig
Prof. Dr. med. Martin Bornhäuser

Universitätsklinikum Carl Gustav Carus Dresden
Medizinische Klinik und Poliklinik der TU Dresden
Fetscherstraße 74
01307 Dresden


Freiberger Straße 33
01067 Dresden

Meeting times

AML Academy
Thursday, 16th November 2023
13:00–19:15 h

SAL autumn meeting
Friday, 17th November 2023
08:00–10:00 h SAL–AMLCG Steering Committee Meeting
10:30–16:00 h Joint Study Group Meeting of SAL, AMLCG


Scandic Hotel Frankfurt Museumsufer
Wilhelm-Leuschner-Straße 44, 60329 Frankfurt am Main

or online via Zoom

Juliana Binder
project manager

Mobile: +49 151 23 33 79 72
Phone: +49 351 25 933 211

Fachbereich Medizin

Tatzberg 47/49
01307 Dresden

Abbvie Deutschland GmbH20.000 €
AMGEN GmbH5.000 €
Astellas Pharma GmbH10.000 €
BeiGene20.000 €
Bristol-Myers Squibb GmbH & Co. KGaA10.000 €
Gilead Sciences GmbH5.000 €
Janssen-Cilag GmbH10.000 €
Jazz Pharma GmbH30.000 €
Neovii5.000 €
Novartis Pharma GmbH10.000 €
Pfizer Pharma GmbH5.000 €
Otsuka Pharma GmbH10.000 €

We like to thank the sponsors for their contributions. The stated amounts are charged exclusively for advertising purposes and stand costs. If you are interested in sponsoring, please contact the event management.

The sponsors that are subject to the FSA code are based on the FSA code, which obliges to transparency. The monetary benefits are documented and published on their website.